(Q45256460)
Statements
1 reference
Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials (English)
1 reference
Matthew Siegel
1 reference
Mitchell E Garber
1 reference
Andrew G Spencer
1 reference
Wendy Botwick
1 reference
Pawan Kumar
1 reference
Robert N Williams
1 reference
Kenji Kozuka
1 reference
Revati Shreeniwas
1 reference
Vijaya Pratha
1 reference
Daniel C Adelman
1 reference
23 September 2011
1 reference
1 reference
57
1 reference
2
1 reference
440-450
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference